Form 4 for ADIL ADIAL PHARMACEUTICALS, INC.

Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-30 · accession 0001213900-22-000067 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-01-03	2021-12-30	ADIL	Newman James W. Jr.	Dir	P - Purchase	$2.66	+10.0K	20.0K	+100%	+$26.6K
MI	2022-01-03	2021-12-30	ADIL	Newman James W. Jr.	Dir	P - Purchase	$2.71	+15.0K	34.6K	+76%	+$40.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-30	P	A	10,000	$2.66	20,000	D Ivy Cottage Group, LLC	—	—	(F1) The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.628 to $2.68, inclusive. The reporting person undertakes to provide Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (6) of this Form 4. (F5) James W. Newman is the general partner of Ivy Cottage Group, LLC.
2	Common	Common Stock	2021-12-30	P	A	5,000	$2.72	50,221	I Roth IRA FBO James W Newman, Jr.	—	—	(F8) Courtney Newman is the daughter of James W. Newman, Jr.
3	Common	Common Stock	2021-12-30	P	A	10,000	$2.71	34,644	I	—	—	(F6) The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.655 to $2.72, inclusive.